bionomics-rgb-1024px.png
Bionomics Investor Webinar
June 13, 2022 16:30 ET | Bionomics Ltd
ADELAIDE, Australia, June 13, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (ASX: BNO |Nasdaq: BNOX ), (Bionomics or the Company), a clinical-stage biopharmaceutical company developing novel,...
bionomics-rgb-1024px.png
Bionomics Limited to Participate in Upcoming Investor Conferences
May 16, 2022 06:00 ET | Bionomics Ltd
ADELAIDE, Australia, May 16, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX | ASX: BNO) (Bionomics or Company), a clinical-stage biopharmaceutical company developing novel, allosteric ion...
bionomics-rgb-1024px.png
Bionomics' Half-Year Report
February 23, 2022 21:00 ET | Bionomics Ltd
ADELAIDE, Australia, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (ASX: BNO, Nasdaq: BNOX), today announced its half-year report for the half-year ended 31 December 2021. The half-year ending...